GGrantIndex
Sort

23,748 grants matching melanoma

Patient-oriented research and mentoring program in dermatologic diseases

$182,535
Maryam Mandana Asgari · Massachusetts General Hospital · K24 · FY2021 · AR

In Vivo Pharmacodynamics of RNAi-based Cancer Therapies

$182,482
Mark E Davis · California Institute Of Technology · U54 · FY2010 · CA

THERAPEUTIC TARGETS IN MELANOMAS

$182,428
Yale University · R01 · FY2001 · CA

U10 Ful Member Application Affiliated with SWOG

$182,372
University Of Texas Md Anderson Can Ctr · U10 · FY2004 · CA

SYNTHESIS AND EVALUATION OF NEW ANTITUMOR AGENTS

$182,357
Arizona State University-Tempe Campus · R01 · FY2000 · CA

Title of Project * L-fucose-mediated enrichment of memory CD4+T cells and enhanced anti-melanoma immunity

$182,325
Eric Kirk Lau · Oregon Health & Science University · R21 · FY2025 · CA

Understanding PD-L1/L2 protein regulation, detection and signaling to predict melanoma therapeutic sensitivity

$182,325
Roger S Lo · University Of California Los Angeles · R21 · FY2021 · CA

Engineered T cells for improved migration into solid tumor sites

$182,325
Jordan Jacobelli · University Of Colorado Denver · R21 · FY2024 · CA

A program of immune-based treatments for cancer

$182,273
William E. Carson · Ohio State University · K24 · FY2010 · CA

A program of immune-based treatments for cancer

$182,272
William E. Carson · Ohio State University · K24 · FY2012 · CA

Admin Core

$182,271
Iman Osman · New York University School Of Medicine · P50 · FY2024 · CA

Tissue Resources Shared Resource

$182,201
Marta Couce · Case Western Reserve University · P30 · FY2022 · CA

(PQ2) HIV INFECTION, APOBEC UPREGULATION, AND CANCER MUTAGENESIS

$182,192
Reuben S Harris · University Of Minnesota · R21 · FY2017 · CA

Integrative genomic biomarkers for predicting response to immunotherapy in melanoma patients

$182,156
Ruth Halaban · Yale University · R21 · FY2018 · CA

Armed oncolytic parvoviral vectors for modulating the tumor microenvironment

$182,156
Peter Tattersall · Yale University · R21 · FY2019 · CA

Novel Strategies to Treat Diffuse Midline Glioma with CAR T Cell Therapy

$182,115
Richard G Vile · Mayo Clinic Rochester · R21 · FY2022 · CA

Cryopreparation of PBMC for Immunotherapy and Immune Assessment Studies.

$182,024
John R Yannelli · University Of Kentucky · R21 · FY2009 · CA

CORE--Biostatistics & Data Management

$182,014
Janiel M Shields · Univ Of North Carolina Chapel Hill · P01 · FY2007 · ES

A Single Cell Multi-Protein Device to Facilitate Cancer Immunotherapy

$181,989
Timothy S McConnell · Isoplexis, Inc. · R43 · FY2015 · CA

Structure-based selection of tumor-antigens for T-cell based immunotherapy

$181,965
Lydia E. Kavraki · Rice University · R21 · FY2016 · CA

Project 2: Chemotherapy-induced Immunomodulation in Colon Cancer

$181,915
Pran K Datta · University Of Alabama At Birmingham · U54 · FY2023 · CA

Project 2: Chemotherapy-induced Immunomodulation in Colon Cancer

$181,913
Pran K Datta · University Of Alabama At Birmingham · U54 · FY2022 · CA

A novel attachment mechanism for Burkholderia cepacia complex

$181,875
Tung T Hoang · University Of Hawaii At Manoa · R21 · FY2024 · AI

BIOSPECIMEN AND PATHOLOGY CORE

$181,863
Sarah M. Dry · University Of California Los Angeles · P01 · FY2016 · CA

BIOSPECIMEN AND PATHOLOGY CORE

$181,863
Sarah M. Dry · University Of California Los Angeles · P01 · FY2017 · CA